Holen Sie sich die Stockscreener-App
0.332
3.11%
0.01
Handel nachbörslich:
.33
-0.002
-0.60%
Schlusskurs vom Vortag:
$0.322
Offen:
$0.32
24-Stunden-Volumen:
414.21K
Relative Volume:
0.69
Marktkapitalisierung:
$40.77M
Einnahmen:
$1.29M
Nettoeinkommen (Verlust:
$-29.87M
KGV:
-0.9222
EPS:
-0.36
Netto-Cashflow:
$-14.70M
1W Leistung:
+5.10%
1M Leistung:
-25.23%
6M Leistung:
-35.60%
1J Leistung:
-58.18%
1-Tages-Spanne:
$0.32
$0.35
1-Wochen-Bereich:
$0.3077
$0.3589
52-Wochen-Spanne:
$0.3077
$0.94
VolitionRX Ltd Stock (VNRX) Company Profile
Firmenname
VolitionRX Ltd
Sektor
Branche
Telefon
646 650 1351
Adresse
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Vergleichen Sie VNRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VNRX
VolitionRX Ltd
|
0.332 | 39.54M | 1.29M | -29.87M | -14.70M | -0.36 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-02-01 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-02-17 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-03-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-16 | Eingeleitet | Maxim Group | Buy |
| 2018-05-14 | Bestätigt | The Benchmark Company | Buy |
| 2016-09-07 | Bestätigt | Rodman & Renshaw | Buy |
| 2016-02-01 | Eingeleitet | Rodman & Renshaw | Buy |
Alle ansehen
VolitionRX Ltd Aktie (VNRX) Neueste Nachrichten
Freedom Capital Markets lowers VolitionRX stock price target on delayed revenue growth - Investing.com Australia
Can VolitionRX Limited stock sustain breakout momentumEarnings Risk Report & Stepwise Trade Execution Plans - newser.com
Will VolitionRX Limited stock beat international competitionQuarterly Earnings Summary & Capital Efficient Trading Techniques - newser.com
What makes VolitionRx Limited stock attractive to growth fundsJuly 2025 Retail & Accurate Trade Setup Notifications - newser.com
Smart tools for monitoring VolitionRx Limited’s price actionWeekly Market Summary & Reliable Breakout Stock Forecasts - newser.com
How strong is VolitionRx Limited stock balance sheet2025 Major Catalysts & Safe Capital Growth Plans - newser.com
How VolitionRX Limited stock trades after rate cutsQuarterly Performance Summary & Expert-Curated Trade Recommendations - newser.com
H.C. Wainwright lowers VolitionRX stock price target on valuation update By Investing.com - Investing.com Nigeria
Are Smart Investors Making the Right Decision? VolitionRX Ltd (VNRX) - Setenews
H.C. Wainwright lowers VolitionRX stock price target on valuation update - Investing.com
VolitionRx price target lowered to $1.50 from $2.50 at H.C. Wainwright - MSN
Reynolds, Volitionrx CEO, buys $7,000 in VNRX stock By Investing.com - Investing.com Australia
Reynolds, Volitionrx CEO, buys $7,000 in VNRX stock - Investing.com
CEO Reynolds Buys 20,000 ($7K) Of VolitionRX Ltd [VNRX] - TradingView
[Form 4] VOLITIONRX LTD Insider Trading Activity - Stock Titan
VolitionRX (VNRX) Target Price Lowered by HC Wainwright & Co. | - GuruFocus
VolitionRX (VNRX): Analyst Jason Kolbert Reaffirms Buy Rating wi - GuruFocus
VolitionRx Limited Reports Q3 2025 Financial Growth - MSN
VolitionRx Ltd. Earnings Call Highlights Growth and Partnerships - The Globe and Mail
Using Ichimoku Cloud for VolitionRx Limited technicalsLong Setup & Detailed Earnings Play Alerts - newser.com
Is VolitionRX Limited stock resilient in recession scenariosSell Signal & High Return Trade Opportunity Guides - newser.com
VolitionRx Limited (AMEX:VNRX) Q3 2025 Earnings Call Transcript - Insider Monkey
Volitionrx Ltd earnings missed by $0.01, revenue fell short of estimates - Investing.com Nigeria
Market reaction to VolitionRx Limited’s recent newsTrade Signal Summary & Technical Pattern Based Signals - newser.com
Earnings call transcript: VolitionRx Ltd reports Q3 2025 revenue growth, stock stable - Investing.com Nigeria
Earnings call transcript: VolitionRx Ltd reports Q3 2025 revenue growth, stock stable By Investing.com - Investing.com South Africa
[SCHEDULE 13G/A] VOLITIONRX LTD SEC Filing - Stock Titan
VolitionRX Ltd (VNRX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Revenue ... By GuruFocus - Investing.com Canada
VolitionRX Ltd (VNRX) Q3 2025 Earnings Call Highlights: Strategi - GuruFocus
VolitionRX Ltd (VNRX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Revenue ... - Yahoo Finance
VolitionRX Q3 2025 Earnings Call Transcript - MarketBeat
VolitionRX: Q3 Earnings Snapshot - CTPost
Volitionrx Ltd earnings missed by $0.01, revenue fell short of estimates By Investing.com - Investing.com Canada
VNRX Advances with Strategic Partnerships and Licensing Deals - GuruFocus
[8-K] VOLITIONRX LTD Reports Material Event | VNRX SEC FilingForm 8-K - Stock Titan
VolitionRx (NYSE American: VNRX) posts Q3 revenue $0.6M; cash used in ops $3.6M - Stock Titan
Regression analysis insights on VolitionRx Limited performanceMarket Growth Review & Risk Controlled Swing Alerts - newser.com
VolitionRX Ltd (VNRX) Q3 2025: Everything You Need to Know Ahead of Earnings - GuruFocus
VolitionRx Limited Announces Third Quarter 2025 Financial Results and Business Update - Yahoo Finance
A Preview Of VolitionRX's Earnings - Benzinga
VolitionRx (NYSE:VNRX) Trading Up 0.6% – Here’s Why - Defense World
[8-K/A] VOLITIONRX LTD Amends Material Event Report | VNRX SEC FilingForm 8-K/A - Stock Titan
Perhaps timely catching VolitionRX Ltd (VNRX) would be a good idea - Setenews
VolitionRx (NYSE American: VNRX) sets Nov. 14 Q3 2025 earnings and business update call - Stock Titan
VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update - Yahoo Finance
Finanzdaten der VolitionRX Ltd-Aktie (VNRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.35%
1.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):